Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 640

GV gives notice on possible $2bn Uber stake sale

The Alphabet unit has already divested part of its stake in publicly-listed Uber to SoftBank at a $48bn valuation but is considering selling the rest from next month.

Oct 7, 2019

Unqork cracks open $80m series B

Unqork has now raised $110m in total, CapitalG having led a series B round featuring earlier backers that include Goldman Sachs Principal Strategic Investments.

Oct 7, 2019

Aeovian achieves $37m series A close

The rare and age-related disease-focused startup emerged from a drug discovery collaboration between Evotec and Apollo Health Ventures, both of which chipped into the round.

Oct 7, 2019

Jambunathan jumps up at SAP

SAP has given Ram Jambunathan, already managing director for SAP.iO, the position of head of corporate strategy.

Oct 6, 2019

Agirman joins Mitsubishi Electric Automotive

Mitsubishi Electric Automotive America has hired Steve Agirman as director of new ventures after four years of corporate venturing at Schneider Electric.

Oct 6, 2019

Venn presses start with $17m

BDMI was among the investors in a seed round raised in preparation for the launch of Venn's gaming and esports television network next year.

Oct 4, 2019

Vouch fills pouch with series A funding

SVB Financial Group co-led a $24.5m round for startup insurance provider Vouch Insurance that will help it pursue geographical expansion in the US.

Oct 4, 2019

Corporate venturing deal net: 30 September-4 October 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Oct 4, 2019

Daily deal net: October 4, 2019

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Oct 4, 2019

Aprea collects $85m in IPO proceeds

Karolinska Institute's Aprea Therapeutics has priced its shares at $15 to raise $85m, with stock rising a third to $20.50 on the first day of trading.

Oct 4, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here